amikacin has been researched along with iopromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Z; Gu, D; Han, Y; He, D; Ren, H; Shi, Y; Xia, T; Yang, J; Zeng, C | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
2 other study(ies) available for amikacin and iopromide
| Article | Year |
|---|---|
AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Urea Nitrogen; Cell Adhesion Molecules; Cell Line; Contrast Media; Creatinine; Disease Models, Animal; Inflammation; Iohexol; Kidney Diseases; Lactate Dehydrogenases; Male; Oxidative Stress; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction | 2020 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |